Fig. 2From: Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?Proposed mechanisms for a SGLT2 inhibitors-induced antiarrhythmic effect in diabetes. SGLT2 sodium-glucose co-transporter 2. Part of illustration elements courtesy of Servier Medical ArtBack to article page